{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T10:07:56Z","timestamp":1767262076454,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005918","name":"Christian Medical College Vellore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005918","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Medical Microbiology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ijmmb.2021.04.005","type":"journal-article","created":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T08:01:35Z","timestamp":1619251295000},"page":"328-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical utility of antifungal susceptibility testing in patients with fungal rhinosinusitis"],"prefix":"10.1016","volume":"39","author":[{"given":"Manju Deena","family":"Mammen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rani Diana","family":"Sahni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George M.","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9892-0064","authenticated-orcid":false,"given":"Vedantam","family":"Rupa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijmmb.2021.04.005_bib1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3390\/medicina55070319","article-title":"Invasive and non-invasive fungal rhinosinusitis-A review and update of the evidence","volume":"55","author":"Deutsch","year":"2019","journal-title":"Medicina"},{"key":"10.1016\/j.ijmmb.2021.04.005_bib2","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s00405-020-05879-y","article-title":"Avoiding repeated surgery in patients with acute invasive fungal sinusitis","volume":"277","author":"Malleshappa","year":"2020","journal-title":"Eur Arch Oto-Rhino-Laryngol"},{"key":"10.1016\/j.ijmmb.2021.04.005_bib3","first-page":"9","article-title":"Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients","volume":"5","author":"Miceli","year":"2012","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ijmmb.2021.04.005_bib4","series-title":"CLSI supplement M61","article-title":"Performance standards for antifungal susceptibility testing of filamentous fungi","author":"CLSI","year":"2017"},{"key":"10.1016\/j.ijmmb.2021.04.005_bib5","series-title":"Interactions of yeasts, moulds, and antifungal agents","first-page":"65","article-title":"Antifungal susceptibility testing: clinical laboratory and standards Institute (CLSI) methods","author":"Fothergill","year":"2012"},{"key":"10.1016\/j.ijmmb.2021.04.005_bib6","series-title":"CLSI standard M38","article-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi","author":"CLSI","year":"2017"},{"key":"10.1016\/j.ijmmb.2021.04.005_bib7","series-title":"CLSI supplement M61","article-title":"Performance standards for antifungal susceptibility testing of filamentous fungi","author":"CLSI","year":"2020"},{"key":"10.1016\/j.ijmmb.2021.04.005_bib8","doi-asserted-by":"crossref","first-page":"S436","DOI":"10.1093\/infdis\/jix210","article-title":"Azole-resistant aspergillosis: epidemiology, molecular mechanisms, and treatment","volume":"216","author":"Chowdhary","year":"2017","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ijmmb.2021.04.005_bib9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12371","article-title":"ESCMID\u2020 and ECMM\u2021 joint clinical guidelines for the diagnosis and management of mucormycosis 2013","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijmmb.2021.04.005_bib10","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1177\/0194599815627786","article-title":"Acute invasive fungal rhinosinusitis: a 15-year experience with 41 patients","volume":"154","author":"Payne","year":"2016","journal-title":"Otolaryngol Neck Surg"},{"key":"10.1016\/j.ijmmb.2021.04.005_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00069-19","article-title":"Antifungal susceptibility testing: current approaches","volume":"33","author":"Berkow","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijmmb.2021.04.005_bib12","series-title":"CLSI supplement M59","article-title":"Epidemiological cutoff values for antifungal susceptibility testing","author":"CLSI","year":"2018"},{"key":"10.1016\/j.ijmmb.2021.04.005_bib13","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1128\/AAC.04435-14","article-title":"Multicenter evaluation of MIC distributions for epidemiologic Cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of mucorales","volume":"59","author":"Espinel-Ingroff","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijmmb.2021.04.005_bib14","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/jac\/dks137","article-title":"In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs","volume":"67","author":"Drogari-Apiranthitou","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.ijmmb.2021.04.005_bib15","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/13693780801975576","article-title":"Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus , and synergy testing for Rhizopus","volume":"46","author":"Arikan","year":"2008","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijmmb.2021.04.005_bib16","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/jac\/dkm518","article-title":"Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole Phase III clinical studies","volume":"61","author":"Espinel-Ingroff","year":"2008","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.ijmmb.2021.04.005_bib17","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3201\/eid1507.090043","article-title":"Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment Failure1","volume":"15","author":"Howard","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijmmb.2021.04.005_bib18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00405-009-1075-8","article-title":"A\u00a0prospective, randomised, placebo-controlled trial of postoperative oral steroid in allergic fungal sinusitis","volume":"267","author":"Rupa","year":"2010","journal-title":"Eur Arch Oto-Rhino-Laryngol"},{"key":"10.1016\/j.ijmmb.2021.04.005_bib19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2500\/ajra.2009.23.3315","article-title":"The role of itraconazole in recalcitrant fungal sinusitis","volume":"23","author":"Seiberling","year":"2009","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.ijmmb.2021.04.005_bib20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00405-012-2096-2","article-title":"Different types of fungal sinusitis occurring concurrently: implications for therapy","volume":"270","author":"Rupa","year":"2013","journal-title":"Eur Arch Oto-Rhino-Laryngol"}],"container-title":["Indian Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085721000608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085721000608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T19:19:32Z","timestamp":1759346372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0255085721000608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0255085721000608"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmmb.2021.04.005","relation":{},"ISSN":["0255-0857"],"issn-type":[{"type":"print","value":"0255-0857"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical utility of antifungal susceptibility testing in patients with fungal rhinosinusitis","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmmb.2021.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Indian Association of Medical Microbiologists. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}